Corcept Therapeutics Shares Down 5.8% Since SmarTrend Said Sell (CORT)

Loading...
Loading...
(via COMTEX News Network)--

SmarTrend identified a Downtrend for Corcept Therapeutics CORT on June 30, 2011 at $3.96. In approximately 4 weeks, Corcept Therapeutics has returned 5.8% as of today's recent price of $3.73.

In the past 52 weeks, shares of Corcept Therapeutics have traded between a low of $2.75 and a high of $5.07 and are now at $3.73, which is 36% above that low price.

Corcept Therapeutics is currently below its 50-day moving average of $4.29 and below its 200-day moving average of $4.06. Look for these moving averages to decline to confirm the company's downward momentum.

In the last five trading sessions, the 50-day MA has fallen 0.91% while the 200-day MA has remained constant.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Corcept Therapeutics.

Write to Chip Brian at cbrian@mysmartrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.mysmartrend.com/signup

Loading...
Loading...
Posted In: Press ReleasesHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...